Showing results (291-300 of 544) with videos related to

Sort By:
Pageof 55
Vaccine: X|September 22, 2023
Using new cold chain technologies to extend the vaccine cold chain in India: Equipment performance, acceptability, systems fit, and costsSandeep Kumar, Mercy Mvundura, Arindam Ray, et al.
Vaccine: X|July 14, 2023
Diabetes incidence before and after COVID-19 vaccination - Results from the German Disease Analyzer databaseBernd Kowall, Karel Kostev, Rüdiger Landgraf, et al.
Vaccine: X|June 22, 2023
Safety profile of inactivated COVID-19 vaccine in indonesian adultsHindra Irawan Satari, Nastiti Kaswandani, Bernie Endyarni Medise, et al.
Vaccine: X|November 6, 2019
Heterogeneity in potential impact and cost-effectiveness of ETEC and Shigella vaccination in four sub-Saharan African countriesJohn D Anderson, Farzana Muhib, Richard Rheingans, et al.
Vaccine: X|November 16, 2020
How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-makingSiobhan Botwright, Anna-Lea Kahn, Raymond Hutubessy, et al.
Vaccine: X|September 3, 2020
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?Marc Hellerstein
Vaccine: X|March 4, 2020
Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country settingTimothy Kinyanjui, Wirichada Pan-Ngum, Sompob Saralamba, et al.
Vaccine: X|January 3, 2022
Pharmacists-physicians collaborative intervention to reduce vaccine hesitancy and resistance: A randomized controlled trialDerar H Abdel-Qader, Wail Hayajneh, Abdullah Albassam, et al.
Vaccine: X|March 18, 2021
The Leptospiral General Secretory Protein D (GspD), a secretin, elicits complement-independent bactericidal antibody against diverse Leptospira species and serovarsEja Schuler, R T Marconi
Vaccine: X|September 2, 2022
Does a pay-for-performance health service model improve overall and rural-urban inequity in vaccination rates? A difference-in-differences analysis from the GambiaAlieu Sowe, Fredinah Namatovu, Bai Cham, et al.
Pageof 55